Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Irina R Suslova"'
Autor:
Vera A Gorbunova, Irina V Kolyadina, Elena I Kovalenko, Liudmila V Manziuk, Elena V Artamonova, Liudmila G Zhukova, Larisa V Bolotina, Tat'iana Iu Semiglazova, Aleksei G Manikhas, Natal'ia A Raevskaia, Il'ia M Itkin, Dmitrii V Filonenko, Larisa A Zhilyaeva, Viktor E Gol'dberg, Natal'ia O Popova, Dmitrii M Ponomarenko, Valentina E Shikina, Irina R Suslova, Olga V Romanchuk, Dmitrii V Kozlov, Ali-Dzarakhmat S Rzaev, Vasilii V Marfutov, Irina I Andreiashkina, Liubov' I Vladimirova, Irina S Mitashok, Natal'ia M Tikhanovskaia, Elena V Karabina, Guzel' Z Mukhametshina, Al'fiia I Khasanova, Sufiia Z Safina, Mikhail V Shaidorov, Dmitrii A Morozov, Elena P Prokof'eva, Liudmila V Kramskaia, Tat'iana V Karandeeva, Irina V Evstigneeva, Elena G Ovchinnikova, Tat'iana P Klement'eva, Olga V Khrupalo, Elena V Tiuvinova, Viktor M Sherstnev, Igor' S Chernov, Dzheims Dzh Kolokolov, Elena A Gaisina, Natal'ia V Levchenko, Viacheslav A Chubenko, Anton Iu Povyshev, Inna V Iudina, Liudmila V Vorotilina, Tat'iana V Andreeva, Garnik S Tumanian, Anton E Koziakov, Liudmila A Gil'mutdinova, Mikhail A Osipov, Alina S Shatokhina, Alena A Vazhenina, Angelina S Chichkanova, Vladimir I Vladimirov, Aleksandr N Ivanov, Anna S Belokhvostova, Elena M Cherniakova, Elena A Tul'china, Svetlana A Maklashova, Oksana N Shkodenko, Iuliia V Kostalanova, Anna V Tarasova, Evgeniia S Kuz'mina
Publikováno v:
Современная онкология, Vol 21, Iss 1, Pp 12-23 (2019)
Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice. Materials and methods. The analysis included 459 patients with advanced BC from 44 federal and mu
Externí odkaz:
https://doaj.org/article/fab8f79eb72a4ebeb4af3ca5e29be2e9
Autor:
Ekaterina V Blinova, Marina O Dudina, Irina R Suslova, Elena A Samishina, Dmitry S Blinov, Dmitry A Roshchin
Publikováno v:
Journal of Advanced Pharmaceutical Technology & Research, Vol 9, Iss 4, Pp 130-134 (2018)
2-Amino-4H-chromene derivatives possess anticancer property proved on different in vivo and in vitro models of malignancies such breast, nasopharyngeal, bladder, ovary carcinomas, astrocytoma, and osteosarcoma. We assumed it might be effective to app
Externí odkaz:
https://doaj.org/article/4924f42077434a3686a7cdc8fc6e6e66
Autor:
Marina O. Dudina, Ekaterina V. Blinova, Inessa Ya. Moiseeva, Elena A. Samyshina, Irina R. Suslova, Dmitrii S. Blinov
Publikováno v:
Кубанский научный медицинский вестник, Vol 26, Iss 1, Pp 101-107 (2019)
The aim was to investigate the acute toxicity of the AX-554 compound following its intragastric administration, as well as to determine the effective cytotoxic concentration and dose of this preparation.Materials and methods. The study was performed
Externí odkaz:
https://doaj.org/article/a9d30e91ac064cd88b77db7f0349e149
Autor:
Marina O. Dudina, Irina R. Suslova, Mariya S. Khalzova, Juliya V. Dergunova, Evgeniya A. Kogan, Dmitry A. Roshchin, Elena A. Samyshina, Mikhail A. Morozov, Sergey S. Dydykin
Publikováno v:
Research Results in Pharmacology, Vol 4, Iss 3, Pp 9-15 (2018)
Introduction. Many anti-tumor drugs have a high potential for toxic damage to liver cells, which makes it necessary to identify molecular mechanisms of the development of the negative impact of drugs on the liver and to develop effective methods for
Externí odkaz:
https://doaj.org/article/e04c1662406445998fabd7ac6b2d6f1e
Autor:
Mikhail V Shaidorov, Elena I. Simolina, Elena V. Artamonova, Denis A. Oskirko, Irina R. Suslova, Ekaterina A. Prokof’eva, Liudmila V. Kramskaia, Dmitrii V. Kozlov, Anton Iu Povyshev, Elena A. Gaisina, Irina I. Andreiashkina, Olga S. Frolova, Elena I. Kovalenko, Liudmila V. Vorotilina, Elena Karabina, Larisa A. Zhiliaeva, Tat'iana V Karandeeva, Guzel' Z Mukhametshina, Dmitrii M Ponomarenko, Artem O. Shepel, Al'fiia I Khasanova, Vasilii V. Marfutov, Valentina E Shikina, Irina V. Evstigneeva, Nataliia O. Popova, Anton E. Koziakov
Publikováno v:
Современная онкология, Vol 22, Iss 1, Pp 53-59 (2020)
The article presents the experience of 19 Russian medical institutions on the use of eribulin in combination with trastuzumab in various treatment lines of metastatic HER2+ breast cancer in routine clinical practice. Aim. The main objective of this r
Autor:
Natal'ia M Tikhanovskaia, Elena Karabina, Igor' S Chernov, Tat'iana V Karandeeva, Mikhail A Osipov, Irina V. Kolyadina, Ali-Dzarakhmat S Rzaev, Dmitrii V. Kozlov, Sufiia Z Safina, Vasilii V. Marfutov, Elena P Prokof'eva, Oksana N Shkodenko, Alena A Vazhenina, Tat'iana V Andreeva, Elena G. Ovchinnikova, Irina R. Suslova, Elena I. Kovalenko, Olga V Khrupalo, Tat'iana Iu Semiglazova, Liudmila V. Vorotilina, Irina I. Andreiashkina, Elena V. Artamonova, Anton Iu Povyshev, Angelina S Chichkanova, Olga V Romanchuk, Vera A Gorbunova, Liubov' I Vladimirova, Elena A. Gaisina, Garnik S Tumanian, Iuliia V Kostalanova, Liudmila A Gil'mutdinova, Irina S Mitashok, Liudmila V Manziuk, Dmitrii M Ponomarenko, Evgeniia S Kuz'mina, Al'fiia I Khasanova, Guzel' Z Mukhametshina, Vladimir I. Vladimirov, Dmitrii A Morozov, Liudmila V. Kramskaia, Mikhail V Shaidorov, V E Goldberg, Inna V Iudina, Valentina E Shikina, Liudmila G. Zhukova, N. O. Popova, Irina V. Evstigneeva, Anton E. Koziakov, Elena A Tul'china, Elena V Tiuvinova, Il'ia M Itkin, Alina S Shatokhina, Aleksei G Manikhas, Dzheims Dzh Kolokolov, Anna S Belokhvostova, Natal'ia V Levchenko, Svetlana A Maklashova, Aleksandr N Ivanov, Larisa Bolotina, Anna V Tarasova, Dmitrii V Filonenko, Viacheslav A. Chubenko, Natal'ia A Raevskaia, Viktor M Sherstnev, Elena M Cherniakova, Tat'iana P Klement'eva, Larisa A Zhilyaeva
Publikováno v:
Современная онкология, Vol 21, Iss 1, Pp 12-23 (2019)
Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice. Materials and methods. The analysis included 459 patients with advanced BC from 44 federal and mu
Autor:
Sergey S. Dydykin, Elena Samyshina, Marina O. Dudina, Irina R Suslova, Evgeniya A. Kogan, Dmitry Roshchin, Juliya V. Dergunova, Mariya S. Khalzova, Mikhail A. Morozov
Publikováno v:
Research Results in Pharmacology, Vol 4, Iss 3, Pp 9-15 (2018)
Research Results in Pharmacology 4(3): 9-15
Research Results in Pharmacology 4(3): 9-15
Introduction. Many anti-tumor drugs have a high potential for toxic damage to liver cells, which makes it necessary to identify molecular mechanisms of the development of the negative impact of drugs on the liver and to develop effective methods for
Publikováno v:
Journal of Advanced Pharmaceutical Technology & Research, Vol 9, Iss 4, Pp 130-134 (2018)
Journal of Advanced Pharmaceutical Technology & Research
Journal of Advanced Pharmaceutical Technology & Research
2-Amino-4H-chromene derivatives possess anticancer property proved on different in vivo and in vitro models of malignancies such breast, nasopharyngeal, bladder, ovary carcinomas, astrocytoma, and osteosarcoma. We assumed it might be effective to app
Autor:
Mikhail Nelipa, Tatiana Demura, Usif Osmanov, Olga Deryabina, Irina R Suslova, E V Blinova, Pavel Zhdanov, Evgenya Kogan, Elena Samishina, Andrey Kaprin, Dmitry Roshchin, D S Blinov
Publikováno v:
Cells
Cells, Vol 8, Iss 6, p 526 (2019)
Volume 8
Issue 6
Cells, Vol 8, Iss 6, p 526 (2019)
Volume 8
Issue 6
Background: Establishment of heterotopic patient-derived xenografts of primary and relapsed non-muscular invasive bladder cancer (NMIBC) to explore the biological property of PD-L1 signaling that may impact bladder tumor growth in humanized animals.
Autor:
Olesia V Kit'ko, D S Blinov, Dmitry Roshchin, Pavel Zhdanov, Olga Deryabina, E V Blinova, Elena Samishina, Irina R Suslova
Publikováno v:
Journal of Carcinogenesis, Vol 18, Iss 1, Pp 3-3 (2019)
Journal of Carcinogenesis
Journal of Carcinogenesis
CONTEXT: Exploration of the biological property of programmed death-ligand 1 (PD-L1) signaling that may impact bladder tumor growth in humanized animals and cell culture. AIMS: The aim of this study is to evaluate how PD-L1 signaling involves bladder